HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 617 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $605,513,015 | +11.6% | 5,233,927 | -0.8% | 0.03% | +21.4% |
Q2 2023 | $542,436,248 | -3.0% | 5,274,052 | +3.0% | 0.03% | -12.5% |
Q1 2023 | $558,997,062 | -53.6% | 5,121,833 | -51.6% | 0.03% | -8.6% |
Q4 2022 | $1,205,441,976 | +239.8% | 10,592,636 | +84.8% | 0.04% | +59.1% |
Q3 2022 | $354,777,000 | -19.8% | 5,732,387 | +3.4% | 0.02% | -15.4% |
Q2 2022 | $442,187,000 | -23.3% | 5,543,974 | +1.2% | 0.03% | -10.3% |
Q1 2022 | $576,388,000 | -2.3% | 5,478,453 | +0.1% | 0.03% | +3.6% |
Q4 2021 | $589,911,000 | -1.0% | 5,474,308 | +0.6% | 0.03% | -12.5% |
Q3 2021 | $596,119,000 | +16.8% | 5,442,017 | -0.2% | 0.03% | +18.5% |
Q2 2021 | $510,424,000 | +27.0% | 5,450,915 | +24.8% | 0.03% | +17.4% |
Q1 2021 | $401,997,000 | +24.5% | 4,367,633 | -1.1% | 0.02% | +15.0% |
Q4 2020 | $322,956,000 | +66.4% | 4,414,988 | +76.7% | 0.02% | +53.8% |
Q3 2020 | $194,045,000 | +38.2% | 2,498,003 | -1.1% | 0.01% | +30.0% |
Q2 2020 | $140,450,000 | +77.9% | 2,526,987 | -5.2% | 0.01% | +42.9% |
Q1 2020 | $78,932,000 | -16.1% | 2,664,837 | +2.6% | 0.01% | +16.7% |
Q4 2019 | $94,030,000 | +33.6% | 2,597,510 | +0.5% | 0.01% | +20.0% |
Q3 2019 | $70,388,000 | +12.7% | 2,584,939 | -0.5% | 0.01% | 0.0% |
Q2 2019 | $62,478,000 | – | 2,596,769 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |